previous compound ID: 2273 next compound
InChIKey: UVTNFZQICZKOEM-UHFFFAOYSA-N
SMILES: CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "SD Macknight" "J Goepp" "J Liao" "E Matthes" "DY Thomas" "GW Carlile" "B Kus" "JW Hanrahan" "R Robert"

chemical graph of compound 2273





CID is 3114
synonyms found at PubChem are:
disopyramide, 3737-09-5, Dicorantil, Rythmodan, Disopiramida, Ritmodan, Disopyramidum, Searle 703, Isorythm, Lispine, Disopyramidum [INN-Latin], Disopiramida [INN-Spanish], Disopyramide Free Base, xi-Disopyramide, Rythmodan-La, Rythmodan P, SC 7031, SC-7031, Rythmodan P (TN), gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide, H 3292, CHEMBL517, alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide, CHEBI:4657, alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide, UVTNFZQICZKOEM-UHFFFAOYSA-N, Disopyramide Monohydrochloride, Disopyramide [USAN:BAN:INN:JAN], EINECS 223-110-2, 4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide, NCGC00015358-18, 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide, Norpace (TN), 2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, D 7644, DSSTox_CID_25536, DSSTox_RID_80938, DSSTox_GSID_45536, 4-(diisopropylamino)-2-phenyl-2-(pyridin-2-yl)butanamide, 4-[bis(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanamide, 2-Pyridineacetamide, alpha-(2-(diisopropylamino)ethyl)-alpha-phenyl-, alpha-[2-[Bis(1-methylethyl)amino]ethyl]-alpha-phenyl-2-pyridine acetamide, 2-Pyridineacetamide, .alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl-, CAS-3737-09-5, 54687-36-4, SR-01000003039, Rythmodan (TN), NCGC00016985-01, Prestwick_681, disopyramide tartrate, Lispine|||Ritmilen, Norpace (Salt/Mix), Spectrum_001008, Prestwick0_000266, Prestwick1_000266, Prestwick2_000266, Prestwick3_000266, Spectrum2_001033, Spectrum3_000404, Spectrum4_000524, Spectrum5_000943, D0M4YC, Lopac0_000402, Lopac0_000411, SCHEMBL16153, BSPBio_000112, BSPBio_001928, KBioGR_001127, KBioSS_001488, MLS002222242, DivK1c_000489, SPBio_001245, SPBio_002331, AC1L1F78, BPBio1_000124, GTPL7167, SC 13957 (Salt/Mix), DTXSID1045536, CTK1H1096, KBio1_000489, KBio2_001488, KBio2_004056, KBio2_006624, KBio3_001148, Disopyramide (JP15/USAN/INN), Disopyramide (JP17/USAN/INN), MolPort-003-846-985, NINDS_000489, HMS1568F14, HMS2095F14, HMS2234G08, HMS3261A06, HMS3369O21, HMS3712F14, Disopyramide [USAN:INN:BAN:JAN], Disopyramide 1.0 mg/ml in Methanol, Tox21_110727, Tox21_500402, BDBM50028893, MFCD00057366, 54687-36-4 (mono-hydrochloride), AKOS015894712, Tox21_110727_1, CCG-204495, DB00280, LP00402, MCULE-8866988334, IDI1_000489, NCGC00015358-04, NCGC00015358-05, NCGC00015358-06, NCGC00015358-08, NCGC00015358-09, NCGC00015358-10, NCGC00015358-11, NCGC00015358-12, NCGC00015358-13, NCGC00015358-14, NCGC00015358-15, NCGC00015358-19, NCGC00093829-01, NCGC00093829-02, NCGC00093829-03, NCGC00261087-01, AC-16018, SMR001307254, 22059-60-5 (phosphate (1:1)), SBI-0050388.P005, LS-185086, AB00053462, D2793, EU-0100402, FT-0667714, ST50411970, Y5028, C06965, D00303, 20509-EP2272972A1, 20509-EP2272973A1, 20509-EP2277872A1, 20509-EP2314585A1, AB00053462_16, AB00053462_17, C-44340, I05-3196, SR-01000003039-3, 4-Diisopropylamino-2-phenyl-2-(2-pyridyl)-butyramide, BRD-A29734509-001-03-8, BRD-A29734509-011-02-9, BRD-A29734509-011-06-0, SR-01000003039-10, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridinyl)butanamide, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridyl)butyramide, Z2786051711, 4-(Diisopropylamino)-2-phenyl-2-(2-pyridinyl)butanamide #, 4-[bis(methylethyl)amino]-2-phenyl-2-(2-pyridyl)butanamide, Disopyramide, European Pharmacopoeia (EP) Reference Standard, .alpha.-(2-(Diisopropylamino)ethyl)-.alpha.-phenyl-2-pyridineacetamide, .gamma.-Diisopropylamino-.alpha.-phenyl-.alpha.-(2-pyridyl)butyramide, 2-Pyridineacetamide, .alpha.-[2-(diisopropylamino)ethyl]-.alpha.-phenyl-, 4-[bis(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanimidic acid, racemic 2-phenyl-2-(2-pyridyl)-4-[N,N-bis(1-methylethyl)amino]butanamide, alpha-[2-[Bis(1-methylethyl)amino]ethyl]- alpha-phenyl-2-pyridine acetamide